These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation. Hu LC, Ding CH, Li HY, Li ZZ, Chen Y, Li LP, Li WZ, Liu WS. J Food Biochem; 2022 May 30; 46(5):e14085. PubMed ID: 35128681 [Abstract] [Full Text] [Related]
5. Inhibition of the hexamerization of SARS-CoV-2 endoribonuclease and modeling of RNA structures bound to the hexamer. Tran DP, Taira Y, Ogawa T, Misu R, Miyazawa Y, Kitao A. Sci Rep; 2022 Mar 09; 12(1):3860. PubMed ID: 35264667 [Abstract] [Full Text] [Related]
9. Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2. Kim Y, Wower J, Maltseva N, Chang C, Jedrzejczak R, Wilamowski M, Kang S, Nicolaescu V, Randall G, Michalska K, Joachimiak A. Commun Biol; 2021 Feb 09; 4(1):193. PubMed ID: 33564093 [Abstract] [Full Text] [Related]
13. Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach. Saeed M, Saeed A, Alam MJ, Alreshidi M. Molecules; 2020 Dec 01; 25(23):. PubMed ID: 33271751 [Abstract] [Full Text] [Related]